New patent for Chiesi drug CLEVIPREX

Annual Drug Patent Expirations for CLEVIPREX Cleviprex is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent for Chiesi drug CLEVIPREX appeared first on Drug…


Generic companies with the most tentative approvals

This chart shows the pharmaceutical companies with the most tentative generic drug approvals in 2020 The Food and Drug Administration (FDA) grants tentative approvals to generic entrants when their generic…
The post Generic companies with the most tent…


Biotechblog